亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Oxford Classic–Defined EMT Risk Stratification of High-Grade Serous Ovarian Cancer for Guiding Treatment Decisions

医学 浆液性液体 内科学 肿瘤科 队列 卵巢癌 危险分层 上皮性卵巢癌 癌症
作者
Lena Rai,Antonella Ravaggi,Eliana Bignotti,Robert L. Hollis,Dale W. Garsed,Ahwan Pandey,Kyriaki-Barbara Papalois,FD Patel,Yasmin Kamel,Leticia Campo,Alistair Easton,Joel Nulsen,Breeshey Roskams-Hieter,Mara Artibani,Lili Wang,Nosheen Hussain,Luyao Wang,Nancy Zaarour,Aneesh Aggarwal,Amro Ahmed-Ebbiary
出处
期刊:Clinical Cancer Research [American Association for Cancer Research]
卷期号:32 (1): 188-202 被引量:1
标识
DOI:10.1158/1078-0432.ccr-24-4250
摘要

Abstract Purpose: The association between epithelial-to-mesenchymal transition (EMT) in high-grade serous ovarian cancer (HGSOC) and poor prognosis is known. However, molecularly defining a subset of tumors that reproducibly associates with poor prognosis has been an elusive goal in this disease. A molecular signature that can robustly identify patients with poor prognosis and guide treatment decisions, including surgical strategy and targeted therapies, can improve survival rates. Experimental Design: We carried out RNA sequencing of 139 tumor samples (Brescia cohort); an external validation on 362 and 126 patients from the Scottish and Garsed cohorts, respectively; and a meta-analysis of 1,023 tumors to develop clinically useful risk groups. Identification of therapeutic targets was carried out by transcriptomic analyses of fluorescence-activated cell sorted (FACS) tumor epithelial cells and multiplex immunofluorescence assessment of tissue sections. Results: In this study, we have validated the prognostic strength of the Oxford Classic–defined EMT in three independent patient cohorts: Brescia [HR = 3.6; 95% confidence interval (CI) of 1.59–7.97; P = 1.99e−03], Scottish (HR = 1.71; 95% CI of 1.08–2.70; P = 2.23e−02), and Garsed (Kruskal–Wallis P = 0.00071). OxC-based risk stratification of HGSOC could robustly identify poor-risk patients with a 5-year median survival for OxC high-risk and OxC low-risk groups of 13% and 50%, respectively (95% CI of 7.1%–23.5% vs. 36.1%–69.3%) in the Brescia cohort. Further analysis of the risk groups suggests that an alternative surgical strategy and a combination therapy involving EMT targeting drugs and immunomodulators could elicit improved clinical response in poor-risk patients. Conclusions: This study provides a clinically useful risk stratification strategy for HGSOC, as well as targeted treatment options for high-risk patients. See related commentary by Venegas et al., p. 10
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
soilman发布了新的文献求助10
1秒前
20秒前
awa606发布了新的文献求助10
25秒前
研友_ZlPolZ完成签到,获得积分10
28秒前
sudeep完成签到,获得积分10
1分钟前
1分钟前
1分钟前
flysteven92完成签到 ,获得积分10
1分钟前
qihongyin发布了新的文献求助10
1分钟前
awa606发布了新的文献求助10
1分钟前
无花果应助留胡子的大楚采纳,获得10
1分钟前
留胡子的大楚完成签到,获得积分10
1分钟前
1分钟前
传奇3应助科研通管家采纳,获得10
2分钟前
2分钟前
bkagyin应助soilman采纳,获得10
2分钟前
2分钟前
soilman发布了新的文献求助10
2分钟前
luluzhu完成签到,获得积分10
2分钟前
11完成签到,获得积分20
2分钟前
852应助awa606采纳,获得10
2分钟前
2分钟前
3分钟前
3分钟前
taku完成签到 ,获得积分10
3分钟前
3分钟前
爆米花应助awa606采纳,获得10
3分钟前
Kao应助科研通管家采纳,获得10
4分钟前
4分钟前
细腻冥王星完成签到,获得积分10
4分钟前
4分钟前
awa606发布了新的文献求助10
4分钟前
yuntong完成签到 ,获得积分0
4分钟前
4分钟前
细腻冥王星关注了科研通微信公众号
4分钟前
可靠往事完成签到,获得积分10
4分钟前
5分钟前
思源应助awa606采纳,获得10
5分钟前
cds完成签到,获得积分10
5分钟前
flyinthesky完成签到,获得积分10
5分钟前
高分求助中
Principles of Economics, 11th Edition 10000
University Physics with Modern Physics, 16th edition 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Arthritis and Related Conditions, An Issue of Orthopedic Clinics 1000
Development of a Bridge Weigh-In-Motion System: A technology to convert the bridge response to the passage of traffic into data on vehicle configurations, speeds, times of travel and weights 1000
ズームレンズの光学設計に関する研究 800
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 700
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7289821
求助须知:如何正确求助?哪些是违规求助? 8909197
关于积分的说明 18856504
捐赠科研通 6957805
什么是DOI,文献DOI怎么找? 3209070
关于科研通互助平台的介绍 2378819
邀请新用户注册赠送积分活动 2184847